OIS at AAO 2015

Eleven Biotherapeutics

Nov 12, 2015 11:17am ‐ Nov 12, 2015 11:25am


Eleven Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applies to the discovery and development of protein therapeutics to treat diseases of the eye.


You must be logged in and own this session in order to post comments.